Pazopanib use preceding curative surgery in low rectal gastrointestinal stromal tumors after imatinib failure: A case report

類似資料

• Pazopanib in metastatic multiply treated progressive gastrointestinal stromal tumors: feasible and efficacious
  著者:: Ramaswamy, Anant, 等
  出版事項: (2016)
• Low prevalence of deficient mismatch repair (dMMR) protein in locally advanced rectal cancers (LARC) and treatment outcomes
  著者:: Ostwal, Vikas, 等
  出版事項: (2019)
• Multimodality therapy of rectal gastrointestinal stromal tumors in the era of imatinib—an Indian series
  著者:: Pai, Vishwas D., 等
  出版事項: (2016)
• Early outcomes of exon 11 mutants in GIST treated with standard dose Imatinib
  著者:: Ramaswamy, Anant, 等
  出版事項: (2017)
• Neoadjuvant imatinib: longer the better, need to modify risk stratification for adjuvant imatinib
  著者:: Ramaswamy, Anant, 等
  出版事項: (2016)